What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea? (Q38365338)

2 September 2017

1 reference

title

What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea? (English)

1 reference

Lia Rita Azeredo Bittencourt

2 September 2017

0 references

Pedro Felipe Carvalhedo de Bruin

3

object named as

Lia Bittencourt

0 references

object named as

Pedro Felipe Carvalhedo de Bruin

2

0 references

author name string

Ivan Guerra de Araújo Freitas

1

1 reference

2 September 2017

Lia Bittencourt

3

1 reference

2 September 2017

Veralice Meireles Sales de Bruin

4

1 reference

2 September 2017

Sérgio Tufik

5

1 reference

2 September 2017

26 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

19

1 reference

2 September 2017

3

1 reference

2 September 2017

755-768

1 reference

https://scigraph.springernature.com/pub.10.1007/s11325-015-1143-9

2 September 2017

0 references

cites work

Biomarkers for cardiovascular disease: challenges and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea: implications for cardiac and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Cardiovascular disorders associated with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea and cardiovascular risk: is metabolic syndrome the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Triggering of nocturnal arrhythmias by sleep-disordered breathing events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Cardiac arrhythmias in obstructive sleep apnea (from the Akershus Sleep Apnea Project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea as a risk factor for stroke and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Independent association between obstructive sleep apnea and subclinical coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea: an emerging risk factor for atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Differing effects of obstructive and central sleep apneas on stroke volume in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Biology of the natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Amino-terminal pro-B-type natriuretic peptide: analytic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effect of nasal continuous positive airway pressure in men on global left ventricular myocardial performance in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Plasma brain natriuretic peptide in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

NT-proBNP is not elevated in patients with obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effects of adenotonsillectomy on R-R interval and brain natriuretic peptide levels in children with sleep apnea: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The epidemiology of adult obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obesity and the lung: 3. Obesity, respiration and intensive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Elevated C-reactive protein in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Diurnal variability of C-reactive protein in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Cysteine: a potential biomarker for obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

The role of oxidative stress in COPD: current concepts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Gamma-glutamyltransferase and diabetes--a 4 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Serum levels of gamma-glutamyl transferase are associated with markers of nocturnal hypoxemia in a general adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Utility of hemoglobin A1c in predicting diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effect of hypoxia on glucose metabolism in nondiabetic patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Adipose tissue-derived factors: impact on health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Adipokines and the cardiovascular system: mechanisms mediating health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Role of adipokines in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Serum leptin and vascular risk factors in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Resistin is closely related to systemic inflammation in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Circulating cell adhesion molecules and death in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1143-9

C-reactive protein and sleep-disordered breathing.

21 January 2018

1 reference

12 December 2020

Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation

1 reference

12 December 2020

Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity

1 reference

12 December 2020

Cardiovascular consequences of obstructive sleep apnoea.

1 reference

12 December 2020

Association between obstructive sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women

1 reference

12 December 2020

Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?

1 reference

12 December 2020

Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome.

1 reference

12 December 2020

Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure

1 reference

12 December 2020

Brain natriuretic peptide as bridge to therapy for heart failure

1 reference

12 December 2020

Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome

1 reference

12 December 2020

Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity

1 reference

12 December 2020

[Hemodynamic and inflammatory markers of sleep apnea-hypopnea syndrome and nocturnal hypoxemia: effects of treatment with nasal continuous positive airway pressure]

1 reference

12 December 2020

Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis

1 reference

12 December 2020

Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome.

1 reference

12 December 2020

Multiple plaque rupture and C-reactive protein in acute myocardial infarction

1 reference

12 December 2020

Molecular signatures of obstructive sleep apnea in adults: a review and perspective.

1 reference

12 December 2020

Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample.

1 reference

12 December 2020

Relationship of heart rate variability to sleepiness in patients with obstructive sleep apnea with and without heart failure

1 reference

12 December 2020

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

12 December 2020

A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis

1 reference

12 December 2020

Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing.

1 reference

12 December 2020

10.1007/S11325-015-1143-9

Identifiers

DOI

1 reference

2 September 2017

1 reference